Investigational Combination Shows Promise in Chronic Hepatitis D

By News Health
32 minutes Ago

(MedPage Today) — WASHINGTON — An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial.
At week 24, the combined response of alanine…

Source link : https://www.medpagetoday.com/meetingcoverage/aasld/118381

Author :

Publish date : 2025-11-09 23:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Assessing SVR at 4 Weeks After Hep C Treatment Proves as Predictive as SVR12

Study Dumps Cold Water on Cholesterol Screening for Kids

Older Kidney Transplant Patients Still See Benefits With Low-Dose Immunosuppression

Interim Data Support Elafibranor in Rare Chronic Liver Disease

Gene Therapy Shows Lipid Improvement but Raises Flags

'There's Nobody There': What We Heard This Week